Literature DB >> 252144

Mortality in meningococcal infections.

B M Andersen.   

Abstract

Among 124 patients with meningococcal infections between 1966-1976, 108 had meningitis with a fatality rate of 7.4%, and 16 septicaemia with 18.8% fatality. High risk patients (more than 3 prognostically unfavourable characteristics) increased from 3.5% 1966-1970 to 15.6% 1971-1976, and the total mortality from 3.6 to 10.4%. The most unfavourable prognostic factor was low blood pressure at admission. High risk patients were more common among those who had meningococci with complete or partial sulfonamide resistance (25.7%) than among those having sensitive meningococci (11.9%). When the meningococci were at least partially sulfonamide-resistant, initial therapy with the combination of benzylpenicillin, sulfaisodimidine and chloramphenicol seemed to be more successful than benzylpenicillin alone in patients above 10 years. Ampicillin was used only in children, and these all survived.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 252144     DOI: 10.3109/inf.1978.10.issue-4.04

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  19 in total

Review 1.  Infections diseases: meningococcal disease.

Authors:  C A Hart
Journal:  West J Med       Date:  2000-08

2.  PCR and restriction endonuclease assay for detection of a novel mutation associated with sulfonamide resistance in Neisseria meningitidis.

Authors:  Désirée E Bennett; Mary T Cafferkey
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

3.  Cloning and characterization of a DNA fragment that confers sulfonamide resistance in a serogroup B, serotype 15 strain of Neisseria meningitidis.

Authors:  B E Kristiansen; P Rådström; A Jenkins; E Ask; B Facinelli; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

4.  Which contacts of patients with meningococcal disease carry the pathogenic strain of Neisseria meningitidis? A population based study.

Authors:  B E Kristiansen; Y Tveten; A Jenkins
Journal:  BMJ       Date:  1998-09-05

Review 5.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  An outbreak of group B meningococcal disease: tracing the causative strain of Neisseria meningitidis by DNA fingerprinting.

Authors:  B E Kristiansen; B Sørensen; B Bjorvatn; E S Falk; E Fosse; K Bryn; L O Frøholm; P Gaustad; K Bøvre
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

7.  Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C.

Authors:  M A Westerink; A A Campagnari; M A Wirth; M A Apicella
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

8.  Meningococcal infections in Scotland 1972-82.

Authors:  R J Fallon; W M Brown; W Lore
Journal:  J Hyg (Lond)       Date:  1984-10

9.  Structural characterization of the lipid A component of pathogenic Neisseria meningitidis.

Authors:  V A Kulshin; U Zähringer; B Lindner; C E Frasch; C M Tsai; B A Dmitriev; E T Rietschel
Journal:  J Bacteriol       Date:  1992-03       Impact factor: 3.490

10.  Transformational exchanges in the dihydropteroate synthase gene of Neisseria meningitidis: a novel mechanism for acquisition of sulfonamide resistance.

Authors:  P Rådström; C Fermér; B E Kristiansen; A Jenkins; O Sköld; G Swedberg
Journal:  J Bacteriol       Date:  1992-10       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.